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INTRODUCTION 
Microsphere
1
 
Recently, insoluble drug carriers for prolonged and 
controlled delivery of therapeutic agents in biological 
system have generated interest.  A microsphere is defined 
as “a monolithic structure of the drug or therapeutic agent 
distributed throughout the matrix either as a molecular 
dispersion or as a dispersion of particles, in the size range 
1-500 μm.”  
Production Technology of Microsphere  
Polymer Phase-Separation Method 
The general outline of the process consists of three steps 
carried out under continuous agitation, they are: 
a) Formation of three immiscible chemical phases. 
b) Deposition of polymer coat upon the core material by 
controlled physical mixing of coating material (while 
liquid) and the core material in the manufacturing vehicle. 
c) The next process involves rigidisation of the coating, 
usually by thermal, cross linking or desolvation 
techniques. 
Emulsification Method (Emulsification Solvent Evaporation/ 
Emulsification Solvent Extraction) 
This technique is based on the evaporation of the internal 
phase of an emulsion by agitation. The formation of solid 
microspheres is brought about by the evaporation of 
volatile solvent at the interface between continuous phase 
and air, this cause partitioning across the interface between 
the dispersed phase and dispersion medium, leading to 
formation of solid microspheres. 
a) Emulsification Solvent Evaporation 
In the emulsification solvent evaporation method, the 
organic solvent of the dispersed phase of emulsion is 
eliminated in two stages. 
i) Diffusion of solvent in disperse phase. 
ii) Elimination of the solvent at disperse phase-air 
interface. 
b) Emulsification Solvent Extraction Method    
In this technique a continuous phase is used which 
immediately extract the solvent of the dispersed phase and 
thus the evaporation stage is no longer 
In practice the volume of dispersing phase can be 
increased by choosing a dispersed phase consisting of co-
solvents, of which at least one has great affinity for the 
dispersing phase. The dispersing phase with two solvents, 
in which one acts as a solvent extractor of dispersed phase 
may be used. 
Spray Drying Technique 
The principle of spray drying rests on the atomization of a 
solution (containing the product to be dried) by 
compressed air or nitrogen through a desiccating chamber 
and drying across a current of warm air. 
It’s an established comparatively low cost encapsulation 
technology that continues to develop. This technique is 
used to protect sensitive substances against oxidation (e.g. 
essential oils, vitamins, colorants, etc.). The matrix 
systems of microsphere type are formed from liquid 
mixtures comprising an active ingredient dispersed with a 
polymer inorganic solvent and the resulting dispersion is 
fed as droplets into heated chamber of spray drier. After 
spray drying a free flowing product is obtained. 
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Fluidized Bed Coating 
The principle of fluidized bed coating or Wurster process 
is that, solid particles are suspended in the stream of air 
and a solution of the coating agent or wall forming agent is 
then sprayed on to the particles. 
Centrifugal Extrusión Techniq
         
In case of centrifugal extrusion, the core and shell material, 
and two mutually immiscible liquids are pumped through a 
spinning two fluids nozzle. This produces a continuous 
two fluid column, which breaks up into a stream of 
spherical droplets which are converted to spheres as they 
fall away from nozzle or are gelled rapidly by collecting in 
a gelling bath. 
Rotational Suspension Separation 
In this process core material dispersed in liquid shell 
formulation is fed to a rotating disk. Individual core 
particles coated with a film of shell formulation are flung 
off the edge of rotating disk along with droplets of pure 
coating material. When shell formulation is solidified by 
cooling, discrete microspheres are produced. The 
technology is claimed to be fast and economic method of 
encapsulating a variety of materials, which are solids. 
Melt Dispersion Technique (Congealable Disperse Phase 
Encapsulation Procedure) 
The drug is dissolved/ dispersed in the molten lipid/wax 
under continuous stirring to form a homogeneous blend. 
During the emulsion step of microsphere preparation, the 
temperature is maintained at about 10°C above the melting 
point of lipid/wax. A dispersant solution, previously heated 
to 5°C above the lipid/wax melting point, is added to the 
melt with constant stirring to form an o/w emulsion. 
Hardening of the oily internal phase (containing lipid/wax 
and drug) and formation of microspheres is accomplished 
by pouring twice the emulsion volume of ice-cold water 
(4°C) into the emulsion. 
Spray Congealing Method 
Spray congealing method is a commercial method of 
forming microspheres. Transition of melt from soft or fluid 
state to solid state is called as congealing. In this 
technique, core material is dispersed in a liquefied coating 
substance and spraying or introducing core-coating 
mixture into some environmental condition, whereby rapid 
solidification of coating is occurred. Coating solidification 
in spray congealing accomplished by thermally congealing 
molten coating material or introducing coating-core 
material mixture into a non-solvent. 
BIOADHESIVE MICROSPHERES AS ORAL DRUG 
DELIVERY
2 
Oral drug delivery is gaining acceptance in terms of 
improving existing concepts and development of new 
technologies in the past few years. There is always 
significant interest in the development of delivery systems 
via the oral route due to patient compliance and 
acceptability. During past decade, gastric retention has 
received much attention with the purpose of maximizing 
the residence of the dosage vehicle in the stomach, thus 
solving a specific absorption window issue or for localized 
drug delivery. 
Several approaches to extend the gastric residence time 
have been investigated including intra-gastric floating 
devices, bioadhesive technology, high-density system, 
magnetic devices, unfoldable, expandable or swellable 
drug delivery systems and super porous hydrogels. 
One of the programs associated with gastric retention is the 
bioadhesive concept, whereby gastric retention can be 
achieved by adhering drug-loaded particles coated with 
specific polymers to the wall of the luminal lining (i.e., the 
mucus layer) with sufficient strength to resist gastric 
emptying. 
Oral delivery is the simplest way of drug administration. In 
oral drug delivery, the microspheres have to pass through 
frequently changing environment in the GIT. There is also 
patient-to-patient variation in GI content, stomach 
emptying time and peristaltic activity, although constraints 
of the oral route are numerous, on the whole, it offers less 
potential danger than the parenteral route. 
The relatively brief transit time of about 12 h through the 
GI tract limits the duration of action that can be expected 
via the oral route. Recently, microspheres made from 
polymers with bioadhesive properties get attached to the 
stomach and prolong the residence time in the stomach.  
Bioavailability of drug with limited solubility in the 
stomach or intestine and small absorption rate constant can 
be improved by increasing the retention time in the 
stomach. Bioadhesive drug delivery system interacts with 
the mucus which is a highly hydrated, viscous anionic 
hydrogel layer protecting the mucosa. The basic structural 
and functional unit of mucus is called as “mucin”. The 
mucin is composed largely flexible glycoprotein chains, 
which are cross-linked. 
Interest in controlled and sustained drug delivery has been 
increased considerably during the past decade. It is now 
possible to employ fairly sophisticated systems, which are 
capable of performing excellent drug release control. The 
regulating insulin delivery system using bioadhesive drug 
delivery is an illustrative example (United States Patent 
No. 6,063). However for oral administration, these systems 
are facing limitations to some extent because of the gastro-
intestinal transit. The duration of most of the sustained 
release product is approximately 8-12 h due to short G.I. 
transit time. Hence, it is necessary to localize the drug 
delivery systems in selected regions of body over extended 
period of time. 
Successful development of an oral controlled release 
delivery system is hampered by the wide fluctuations in its 
GI residence time. Different approaches for prolonging GI 
residence time include the use of…: 
 Multiunit dosage form 
 Intra-gastric floating drug delivery system (IGF) 
 Sandwich – type polymeric delivery system 
 Density based dosage forms 
 Particle size relevant to stomach retropulsion 
 Bioadhesive delivery system 
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One of the approaches of gastro retention is to employ 
bioadhesive polymer that adhere to mucin /epithelial cell 
surface.  
BIOADHESION
3 
The term bioadhesion is defined as the attachment of 
synthetic or natural macromolecules to mucus and/or 
epithelial surface. Bioadhesive drug delivery systems are 
delivery systems, which utilize the property of bioadhesion 
of certain polymers, which become adhesive on hydration 
and hence, can be used for targeting of a drug to a 
particular region of the body for extended periods of time. 
Bioadhesion is an interfacial phenomenon in which the 
two materials, at least one of which is biological, are held 
together by means of interfacial forces an artificial 
material and biological substrate, such as adhesion 
between a polymer and a biological membrane. In the case 
of polymer attached to mucin layer of a mucosal tissue, the 
term “bioadhesion” is used. The mucosal layer lies in 
number of regions of the body including gastrointestinal 
tract, urinogenital tract, ear, nose and eye. These mucosal 
layers represent potential sites for attachment of any 
bioadhesive system. Bioadhesive drug delivery approach 
to decrease the rate of GI transit of a drug is based on 
employing polymer that bind to the GI mucin of epithelial 
cell surfaces and are thus retained in the stomach or 
intestine for extended periods of time. Bioadhesive 
polymers would be useful when applied to any mucus, and 
perhaps non-mucus, membranes as well by increasing the 
intimacy and duration of contact of a drug with absorbing 
membrane. 
Adhesion can be defined as the bond produced by contact 
between a pressure sensitive adhesive and a surface. 
American Society of Testing and Materials, 1984 has 
defined it as the state in which two surfaces are held 
together by interfacial forces which may consist of valence 
forces inter locking action or both. 
It is also defined as the ability of a material (synthetic or 
biological) to adhere to a biological tissue for an extended 
period of time. 
In biological systems four types of bioadhesion can be 
distinguished such as; 
1. Adhesion of a normal cell on another normal cell, 
2. Adhesion of a cell with a foreign substance, 
3. Adhesion of a normal cell to a pathological cell, 
4. Adhesion of an adhesive to a biological substrate. 
Bioadhesive are classified into three types based on 
observable fact, rather than on the mechanisms of 
bioadhesion. 
A. Type I 
Bioadhesion is characterized by adhesion occurring 
between biological objects without involvement of 
artificial materials. Examples are Cell fusion and cell 
aggregation. 
B. Type II 
Bioadhesion can be represented by cell adhesion onto 
culture dishes or adhesion to a variety of substances 
including metals, woods and synthetic materials. 
C Type III 
Bioadhesion can be described as adhesion of artificial 
substances to biological substrates such as adhesion of 
polymers to skin or other soft tissues. 
The aim of the development of bioadhesives are to 
duplicate, mimic or improve biological adhesion, which 
are both durable where required and degradable where 
necessary and non toxic at all. Bioadhesive drug delivery 
systems utilize the property of bioadhesion of certain 
water-soluble polymers which become adhesive on 
hydration and hence, it can be used for targeting a drug to 
a particular region of the body for extended periods of 
time. 
The mucosal layer lines a number of regions of the body 
including the GI tract, the urogenital tract, the ear nose and 
eye. These represent potential sites for attachment of any 
bioadhesive system and hence, the bioadhesive drug 
delivery systems may include the following  
1. Buccal delivery system 
2. Sublingual delivery system 
3. Vaginal delivery system 
4. Rectal delivery system 
5. Nasal delivery system 
6. Ocular delivery system 
7. Gastrointestinal delivery system 
 Use of Bioadhesive Preparations
 
The idea of bioadhesion was derived from the need to 
localize drugs at a certain site in the body. Often, the 
extent of drug absorption is limited by the residence time 
of the drug at the absorption site. For example, in ocular 
drug delivery, less than 2 min. are available for drug 
absorption after instillation of a drug solution into the eye, 
since it is removed rapidly by solution drainage and hence 
the ability to extend contact time to an ocular drug delivery 
system in front of the eye would undoubtedly improve 
drug bioavailability. In oral drug delivery, the drug 
absorption is limited by the GI transit time of the dosage 
form. Since many drugs are absorbed only from the upper 
small intestine, localizing oral drug delivery system in the 
stomach or in the duodenum would significantly improve 
the extent of drug absorption. 
Since most of the routes of drug administration such as 
ocular, nasal, buccal, respiratory, gastrointestinal, rectal 
and vaginal are coated with the mucus layer, bioadhesive 
are expected to increase the residence time. In addition, 
they provide intimate contact between a dosage form and 
the absorbing tissue which may result in high drug 
concentration in a local area and hence high drug flux 
through the absorbing tissue, furthermore, the intimate 
contact may increase the total permeability of high 
molecular weight drugs such as peptides and proteins. 
 Advantages of Bioadhesive Drug Delivery System
4  
Some of the advantages of bioadhesive drug delivery 
system are as follows  
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1. It localizes drug in a particular region thereby 
improving and enhancing bioavailability for those 
drugs with bioavailability problems. 
2. The long interaction between polymer and mucus 
lining of the tissue helps to increase contact time and 
permit localization, an essential issue when 
modification of tissue permeability is important for 
delivery e.g. peptides/proteins and ionized species. 
3. It can be helpful to inhibit metabolizing enzymes in 
localized area. 
4. It delivers agents locally for the purpose of modulating 
antigenicity. 
In most instances, the bioadhesive polymer is in contact 
with a soft tissue (buccal, intestinal, nasal, etc.) and thus 
the tissue layer responsible for formation of adhesive 
interface is mucus5. 
 
 
 
 
 
 
 
 
 
 
Figure1: Representation of Mucus  
 
 
BIOADHESIVE POLYMERS
6 
These are generally hydrophilic macromolecules that 
contain the numerous hydrogen bond forming groups (e.g.:  
hydroxyl and carboxyl groups) and will hydrate and swell 
when placed in contact with water. In most cases, these 
materials require wetting to become adhesive. However, 
over-hydration may result in the formation of slippery 
mucilage and a loss of adhesive properties  
The adhesive bond between a bioadhesive system and a 
mucus gel can be investigated in terms of the contribution 
of the following three reasons: 
 The surface of bioadhesive polymer. 
 The interfacial layer between the bioadhesive material 
and the mucosa. 
 The mucosal surface. 
Furthermore, it is reasonable to suggest that an increase in 
the mechanical strength of the mucus layer by the 
bioadhesive polymer could result in the strong 
bioadhesion. 
Many types of forces can be used to anchor a polymer to a 
mucus and /or tissue surface. Covalent forces are suitable, 
provided the polymeric material is nontoxic to the tissue. 
More likely polymer candidates will be those that are 
capable of either weak polar or electrostatic interactions. 
Undoubtedly, the ultimate force for any polymeric material 
attached to a tissue will be a combination of forces 
including hydrophilic and hydrophobic. 
It is also clear that strong interaction between chemicals 
groups on the polymer and mucus/tissue are needed to 
keep the dosage form in contact with the tissue for an 
intended period of time. 
An ideal polymer for bioadhesive drug delivery should 
have following characteristics: 
1. The polymer and its degradation products should be 
non-toxic and non-absorbable from gastro-intestinal 
tract. 
2. It should be non-irritant to the mucous membrane. 
3. It should preferably form a strong non-covalent bond 
with the mucin epithelial cell surface. 
4. It should adhere quickly to moist tissue and should 
possess some site specificity. 
5. It should possess some sustained release property. 
6. It should allow easy incorporation of drug and offer 
no hindrances to its release. 
7. It must not decompose on storage or during life of the 
dosage form. 
8. The cost should not be high; so that the prepared 
product remains competitive. 
 Classification of Bioadhesive Polymer
7 
Many bioadhesives are made up of either synthetic or 
natural polymers. Most of synthetic bioadhesive polymers 
are either polyacrylic acid or cellulose derivatives. 
Examples of polyacrylic acid based polymers are carbopol, 
polycarbophill, polyacrylic acid (PAA), polyacrylate, poly 
(methylvinylether-co-methacrylic) acid and poly 
(methacrylate). Cellulosics include carboxy 
methylcellulose, sodium carboxy methylcellulose, 
methylcellulose and hydroxypropyl methylcellulose. In 
addition (semi) natural bioadhesive polymers include CH 
and various gums such as guar, xanthenes, pectin and 
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alginate. Finally poly (vinylpyrrolidone) and poly (vinyl 
alcohol) can be included as synthetic bioadhesive polymers  
In more functional type of classification bioadhesive 
polymers can be grouped into: 
 Water soluble polymers, which are typically linear or 
random e.g. PAA. 
 Water insoluble polymers, which are form a swellable 
network, by covalent or ionic bonds via cross-linking 
agent e.g. Polycarbophil. 
In case of water-soluble polymers, the duration of 
residence time on tissue surfaces is based on dissolution 
rate of polymer. In contrast cross- linked polymers have a 
residence time based on the rate of mucus/tissue turnover 
due to the lack of solubility in common solvents. Choice of 
a particular polymer type and perhaps specific polymer 
will depend on a number of formulation issues as well as 
patient status. 
The development of adhesive dosage forms for controlled 
drug delivery to or via mucus membranes is of interest 
with regard to local drug therapy, and the systemic 
administration of peptide and other drug poorly absorbed 
from the GIT. The bioadhesive materials have been 
identified as hydrophilic macromolecules containing 
numerous hydrogen bond forming groups, particularly 
carboxyl groups. They become adhesive on hydration so 
referred as wet adhesive. 
 Mechanism of Bioadhesion
4 
A complete understanding of how and why certain 
macromolecules attach to a mucosal tissue surface is not 
yet available but certain elements of the process are clear. 
The bioadhesive must spread over the substrate to initiate 
the intimate contact and to increase the surface area of 
contact. Chains of the adhesive can inter-diffuse in to the 
mucus substrate to create a greater area of contact. Forces 
of attraction and repulsion develop and for successful 
bioadhesive, the attractive forces dominate. Each of these 
steps can be facilitated by the nature of the dosage form 
and how it is applied. Thus, an increase in applied pressure 
will contribute to intimate contact by causing viscoelastic 
deformation at the interface. Moreover, a partially 
hydrated polymer will be drawn to the substrate surface. 
A more complete and comprehensive bioadhesion that 
predicts the adhesions based on the chemical or physical 
nature of a particular polymer is not yet available. 
However, there are four classic theories of bioadhesion. 
Electronic Theory 
The adhesive polymer and mucus typically have different 
electronic characteristics. When these two surfaces come 
in contact, a double layer of electrical charges forms at the 
interface and then adhesion develops due to the attractive 
force from electron transfer across the electrical double 
layer. 
Adsorption Theory
 
In the adsorption theory, a bioadhesive polymer adheres to 
mucus because of secondary surface forces such as Van 
Der wall’s forces, hydrogen bonds, or hydrophobic 
interactions for a bioadhesive polymer with a carboxyl 
group. Hydrogen bonding is considered to be the dominant 
force at the interface. On the other hand, hydrophobic 
interactions can explain the fact that a bioadhesive may 
bind to hydrophobic substrate more tightly than to a 
hydrophilic surface. 
Wetting Theory 
Primarily applicable to liquid bioadhesive systems, the 
wetting theory emphasizes the intimate contact between 
the adhesive and mucus. Thus a wetted surface is 
controlled by structural similarity, degree of cross linking 
of the adhesive polymer or use of a surfactant. 
Diffusion Theory 
The chains of the adhesive and the substrate interpenetrate 
one another to a sufficient depth to create a semi 
permanent adhesive bond. The penetration rate depends on 
the diffusion coefficients of both interacting polymer. The 
diffusion coefficient is known to be dependent on 
molecular weight and cross linking density. In addition, 
segment mobility, flexibility of bioadhesive polymer, 
mucus glycoprotein, and the expanded nature of both 
networks are important parameters that need to be 
considered. 
These general theories are not particularly useful in 
establishing of mechanistic pace to modern bioadhesive 
but they do identify variables that are important to 
bioadhesion process. 
Stages of Bioadhesion
3 
Bioadhesion is believed to occur in following three stages:  
 Wetting. 
 Interpenetration. 
 Mechanical interlocking between mucin and polymer 
Hydrocolloids are believed to adhere to mucosa upon 
hydration, as the synthetic polymer molecules become 
more freely mobile and are able to orientate adhesive sites 
favorably with those of the substrate. As the level of 
hydration increases, adhesive strength was found to 
decrease, since bioadhesive bonds become overextended. 
It is proposed that hydrogen bond forming capacity of the 
polymer is important in this effect and may emphasize the 
well-documented bioadhesive properties of polymers 
possessing numerous carboxyl groups such as Carbopol 
and Polycarbophil. However, greater the swelling property 
of the polymer, greater is the ionization, which may lead to 
a reduction in mechanical strength and concomitant 
reduction in bioadhesive properties (Jain, 2003). Based on 
the bioadhesion theories, it may be concluded that the most 
efficient bioadhesive polymer has physicochemical 
properties that are closely related to those of the mucus 
substrate. 
Factors Affecting Bioadhesion 
Polymer Related Factors 
a) Molecular Weight 
Numerous studies have indicated that at certain molecular 
weight bioadhesion is at a maximum. The interpenetration 
of polymer molecules is favorable for low molecular 
weight whereas entanglements are favored for high 
molecular weight polymers. The optimum molecular 
weight for the maximum bioadhesion depends on the type 
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of polymers. Their nature dictates the degree of swelling in 
water, which in turn determines interpenetration of 
polymer molecules within the mucus. The bioadhesive 
force increases with the molecular weight of the 
bioadhesive polymer, up-to 100,000 and beyond this level 
there is not much effect. To allow chain interpenetration, 
the polymer molecule must have an adequate length. Size 
and configuration of the polymers molecule are also 
important factors. For example with polyethylene oxide 
adhesive strength increases even up-to molecular weight of 
4,000,000, these polymers are well known to contain 
molecules of highly linear configuration, which contribute 
to interpenetration with Dextran, molecules with molecular 
weights as high as 19,500,000 do not exhibit better 
bioadhesion that of molecules with a molecular weight of 
2,00,000. 
b) Concentration of Active Polymer 
There is optimum concentration of polymer corresponding 
to the best bioadhesion. In highly concentrated systems, 
the adhesive strength drops significantly. In fact, in 
concentrated solutions, the coiled molecules become 
solvent poor and the chains available for interpenetration 
are few. This result seems to be of interest only for more or 
less liquid bioadhesive forms.  
c) Flexibility of Polymer Chains 
It is important for interpenetration and enlargement, as 
water-soluble polymers become cross linked, the mobility 
of the individual polymer chain decreases. As the cross 
linking density increases, the effective length of the chain 
which can penetrate into the mucus layer decreases even 
further and bioadhesive strength is reduced. 
d) Spatial Conformation 
Besides molecular weight or chain length, spatial 
conformation of molecule is also important. Despite a high 
molecular weight of 1,95,00,000 for dextrans, they have 
similar adhesive strength to that of polyethylene glycol 
with a molecular weight of 2,00,000. The helical 
conformation of dextran may shield many adhesively 
active groups, primarily responsible for adhesion, unlike 
PEG polymers which have a linear conformation. 
Environment Related Factors 
a) pH 
pH was found to have significant effect on bioadhesion as 
observed in studies of polyacrylic polymers cross linked 
with COOH groups. pH influences the charge on the 
surface of both mucus and the polymers. Mucus will have 
a different charge density depending on pH because of 
differences in dissociation of functional groups on the 
carbohydrate moiety and amino acids of the polypeptide 
backbone. 
It was observed that the pH of the medium was critical for 
the degree of hydration of highly cross linked polyacrylic 
acid polymers, increasing between pH 4 and pH 5, 
continuing to increase lightly at pH 6 and pH 7 and 
decreasing at more alkaline pH levels. This behavior was 
attributed to differences in charge density at different pH. 
Polycarbophil showed maximum adhesive strength at pH 
3, the adhesive strength decreases gradually as the pH 
increases up-to 5. Polycarbophil did not show any 
bioadhesive property above pH 5. This study was the first 
systematic investigation of the mechanism of bioadhesion, 
which clearly showed that the protonated carboxyl groups 
rather than ionized carboxyl groups react with mucin 
molecules, presumably by numerous simultaneous 
hydrogen bonding. At pH above, polycarbophil swells to a 
large extent than at pH 3 or below. At high pH, however, 
the chains are fully extended because of the electrostatic 
repulsion of carboxylate anions. The polymer chains are 
also repelled by the negatively charged mucin molecules. 
It has been also observed that, due to hydrogen bonding 
between hydroxypropyl cellulose and CP934P, 
interpolymer complexes form at pH values below 4.5. 
b) Applied Strength 
To place a solid bioadhesive system, it is necessary to 
apply a defined strength. Whatever the polymer, poly 
(acrylic acid / Divinyl benzene poly (HEMA) or CP934P, 
the adhesion strength increases when applied to the tissue 
contact site can affect the depth of interpenetration. If high 
pressure is applied for a sufficiently long period of time, 
polymers become bioadhesive even though they do not 
have attractive interactions with mucin. 
c) Initial Contact Time 
The initial contact time between bioadhesives and the 
mucus layer determines the extent of swelling and the 
interpenetration of polymer chains. Along with the initial 
pressure, the initial contact time can dramatically affect the 
performance of the system. The bioadhesive strength 
increases as the initial contact time increases. In case of 
bioadhesive that need to be polymerized at the application 
sites, the initial contact time is critical. It is easily 
controlled when bioadhesive are applied to exposed areas 
such as eye, nose or mouth. For the application of 
bioadhesive to the GIT, however, the initial contact time 
cannot be controlled, which is one of the difficulties in 
applying bioadhesive to the GIT. 
d) Selection of Model Substrate Surface 
The handling and treatment of biological substrates during 
the testing of bioadhesive is an important factor, since 
physical and biological changes may occur in the mucus 
gels or tissues under the experimental conditions. The 
viability of the biological substrate should be confirmed by 
examining properties such as permeability, 
electrophysiology or histology. Such studies may be 
necessary before and after performing the in vitro test 
using tissues. 
e) Swelling 
This characteristic is related to the polymer itself, and also 
to its environment. Interpenetration of chains is easier as 
polymer chains are disentangled and free of interactions. 
Swelling depends both on polymer concentration and on 
presence of water. When swelling is too great, a decrease 
in bioadhesion occurs. Such a phenomenon must not occur 
too early in order to lead to sufficient action for the 
bioadhesive system. Its appearance allows easy 
detachment of the bioadhesive system after the discharge 
of the active ingredient. 
 Physiological Variables8 
a) Mucin Turnover 
Borade et al                                Journal of Drug Delivery & Therapeutics; 2013, 3(2), 176-185   182 
© 2011, JDDT. All Rights Reserved                                                        ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
The natural turnover of mucin molecules from the mucus 
layer is important for at least two reasons. First, the mucin 
turnover is expected to limit the residence time of the 
bioadhesive on the mucus layer. No matter, how high the 
bioadhesive strength, bioadhesive are detached from the 
surface due to mucin turnover. The turnover rate may be 
different in the presence of bioadhesive; however no 
information is available on this aspect so far. Secondly, 
mucin turnover results in substantial amount of soluble 
mucin molecules. These molecules interact with 
bioadhesive before they have a chance to interact with the 
mucus layer. Surface fouling is unfavorable for 
bioadhesion to the tissue surface. Mucin turnover may 
depend on other factors such as the presence of food. The 
gastric mucosa accumulates secreted mucin on the luminal 
surface of the tissue during the early stages of the fasting. 
The accumulated mucin is subsequently released by 
freshly secreted acid or simply by the passage of ingested 
food, the exact turnover rate of the mucus layer remains to 
be determinedcalculated a mucin turnover time of 47-200 
min. The ciliated cells in the nasal cavity are known to 
transport the mucus to the throat at a rate of 5 mm/min. 
The mucociliary clearance in the tracheal region has been 
found to be in the range of 4-10 mm/min. 
b) Disease States 
The physiochemical properties of the mucus are known to 
change during disease conditions such as common cold, 
gastric ulcers, ulcerative colitis, cystic fibrosis, bacterial 
and fungal infections of the female reproductive tract and 
inflammatory conditions of the eye. The exact structural 
changes taking place in mucus under these conditions are 
not clearly understood. If bioadhesive are to be used in the 
disease state, the bioadhesive property needs to be 
evaluated under the same conditions. 
EVALUATION OF BIOADHESIVE 
MICROSPHERES
 
The best approach to evaluate bioadhesive microspheres is 
to evaluate the effectiveness of bioadhesive polymer to 
prolong the residence time of drug at the site of absorption, 
thereby increasing absorption and bioavailability of the 
drug. The methods used to evaluate bioadhesive 
microspheres include the following. 
Measurement of Adhesive Strength / in- Vitro Tests
9 
The quantification of the bioadhesive forces between 
polymeric microspheres and the mucosal tissue is a useful 
indicator for evaluating the bioadhesive strength of 
microspheres. In- vitro techniques have been used to test 
the polymeric microspheres against a variety of synthetic 
and biological tissue samples, such as synthetic and natural 
mucus, frozen and freshly excised tissue, etc. The different 
in- vitro methods include the following: 
a) Tensile Stress Measurement Wilhelmy Plate Technique10 
The Wilhelmy plate technique is traditionally used for the 
measurement of dynamic contact angles and involves the 
use of a microtensiometer or a microbalance. The CAHN 
dynamic contact angle analyser (model DCA 322, CAHN 
instruments, Cerritos) has been modified to perform 
adhesive microforce measurements. The DCA 322 system 
consists of an IBM compatible computer and a 
microbalance assembly). The microbalance unit consists of 
stationary sample and tare loops and a motor powered 
translation stage. The instrument measures the bioadhesive 
force between mucosal tissue and a single microsphere 
mounted on a small diameter metal wire suspended from 
the sample loop in microtensiometer The tissue, usually rat 
jejunum, is mounted within the tissue chamber containing 
Dulbecco’s phosphate buffered saline containing 100 
mg/dl glucose and maintained at the physiologic 
temperature. The chamber rests on a mobile platform, 
which is raised until the tissue comes in contact with the 
suspended microsphere. The contact is held for 7 min, at 
which time the mobile stage is lowered and the resulting 
force of adhesion between the polymer and mucosal tissue 
is recorded as a plot of the load on microsphere versus 
mobile stage distance or deformation. The plot of output of 
the instrument is unique in that it displays both the 
compressive and the tensile portions of the experiment. By 
using the CAHN software system, three essential 
bioadhesive parameters can be analyzed. These include the 
fracture strength, deformation to failure and work of 
adhesion. 
b) Fracture Strength 
It is the maximum force per unit surface area required to 
break the adhesive bond. 
c) Deformation to Failure 
It is the distance required to move the stage before 
complete separation occurs. This parameter is dependent 
on the material stiffness and the intensity of strength of 
adhesion. 
d) Work of Adhesion 
It is a function of both the fracture strength and the 
deformation to failure. It tends to be the strongest indicator 
of the bioadhesive potential. This technique allows the 
measurement of bioadhesive properties of a candidate 
material in the exact geometry of the proposed 
microsphere delivery device and the use of a physiological 
tissue chamber mimics the in-vivo conditions. From a 
single tensile experiment, 11 bioadhesive parameters can 
be analyzed out of which 3 are direct predictors of the 
bioadhesive potential). The CAHN instrument, although a 
powerful tool has inherent limitations in its measurement 
technique, makes it better suited for large microspheres 
(with a diameter of more than 300 µm) adhered to tissue 
in-vitro. 
Novel Electromagnetic Force Transducer (EMFT)11 
The EMFT is a remote sensing instrument that uses a 
calibrated electromagnet to detach a magnetic loaded 
polymer microsphere from a tissue sample. It has the 
unique ability to record remotely and simultaneously the 
tensile force information as well as high magnification 
video images of bioadhesive interactions at near 
physiological conditions. The EMFT measures tissue 
adhesive forces by monitoring the magnetic force required 
to exactly oppose the bioadhesive force. To test a 
microsphere, it must first be attached to the sample of 
tissue; magnetic force is then generated by an 
electromagnet mounted on the microscope vertically above 
the tissue chamber. After the computer has calculated the 
position of microsphere, the tissue chamber is slowly 
moved down, away from the magnet tip. As the tissue 
slowly descends away from the magnet, the video analysis 
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continuously calculates the position of microsphere until 
the latter is completely pulled free of the tissue. The 
computer can display the results either as raw data or 
convert it to a force versus displacement graph. The 
primary advantage of the EMFT is that no physical 
attachment is required between the force transducer and 
the microsphere. This makes it possible to perform 
accurate bioadhesive measurements on the small 
microspheres, which have been implanted in vivo and then 
cut (along with the host tissue) for measurement. This 
technique can also be used to evaluate the bioadhesion of 
polymers to specific cell types and hence can be used to 
develop bioadhesive drug delivery systems to target-
specific tissues. 
Shear Stress Measurement12 
The shear stress measures the force that causes a 
bioadhesive to slide with respect to the mucus layer in a 
direction parallel to their plane of contact. Adhesion tests 
based on the shear stress measurement involve two glass 
slides coated with polymer and a film of mucus. Mucus 
forms a thin film between the two polymer coated slides, 
and the test measures the force required to separate the two 
surfaces. Mikos and Peppas, 1990 designed the in-vitro 
method of flow chamber. The flow chamber made of 
Plexiglass is surrounded by a water jacket to maintain a 
constant temperature. A polymeric microsphere placed on 
the surface of a layer of natural mucus is placed in a 
chamber. A simulated physiologic flow of fluid is 
introduced in the chamber and movement of microsphere 
is monitored using video equipment attached to a 
goniometry, which also monitors the static and dynamic 
behavior of the microparticle. 
Other Tests to Measure the Adhesive Strength 
a) Adhesion Number 
Adhesion number for bioadhesive microspheres is 
determined as the ratio of the number of particles attached 
to the substrate to the total number of applied particles, 
expressed as a percentage. The adhesion strength increases 
with an increase in the adhesion number. 
b) Falling Liquid Film Method13 
It is a simple, quantitative in situ method, wherein an 
excised intestinal segment cut lengthwise, is spread on a 
plastic flute and positioned at an inclined angle. The 
suspension of microspheres is allowed to flow down the 
intestinal strip. Particle concentrations entering the 
segment from the dilute suspension reservoir and leaving 
the intestinal segment can be determined with the help of 
Coulter counter to quantify the steady state fraction of 
particles adhered to the intestinal mucosa. The percent of 
particles retained on the tissue is calculated as an index of 
bioadhesion.  
c) Everted Sac Technique14 
The everted intestinal sac technique is a passive test for 
bioadhesion testing and involves polymeric microspheres 
and a section of the everted intestinal tissue. It is 
performed using a segment of intestinal tissue excised 
from the rat, everted, ligated at the ends and filled with 
saline. It is then introduced into a tube containing a known 
amount of the microspheres and saline, and agitated while 
incubating for 30 min. Sac is then removed, microspheres 
are washed and lyophilized, and the percentage of binding 
to the sac is calculated from difference in the weight of the 
residual spheres from the original weight of the 
microspheres. The advantage of the technique is that no 
external force is applied to the microspheres being tested; 
microspheres are freely suspended in buffer solution and 
made to come in contact with the everted intestinal tissue 
randomly. The CAHN technique and the everted intestinal 
sac technique, both predict the strength of bioadhesion in a 
very similar manner. Santos et al., 1999established a 
correlation between the two in-vitro bioadhesion assay 
methods which thereby allows one to confidentially utilize 
a single bioadhesion assay to scan a variety of bioadhesive 
polymers. 
d) Novel Rheological Approach15 
The rheological properties of the bioadhesive interface (i.e. 
of the hydrated gel) are influenced by the occurrence of 
interpenetration step in the process of bioadhesion. Chain 
interlocking, conformational changes and the chemical 
interaction, which occur between bioadhesive polymer and 
mucin chains produce changes in the rheological behaviour 
of the two macromolecular species. The rheological 
studies provide an acceptable in-vitro model representative 
of the in-vivo behaviour of bioadhesive polymers Due to 
intermolecular interactions between the two polymers 
(mucin and the bioadhesive polymer), experimentally 
measured viscosity of the mixture is generally higher than 
the viscosity calculated as a weighted average of the 
viscosities of the individual components. Thus, the 
magnitude of the intermolecular interactions can be 
quantitated by the relative change of the solution viscosity. 
A synergistic increase in the viscosity of the gastric mucus 
glycoprotein has been observed with polyacrylates, which 
thereby reinforce the gastro-duodenal mucus. It has been 
reported that an optimum polymer concentration is 
required for rheological synergy to be evident, above 
which any synergy is masked by the rheological properties 
of the polymer alone. The effect of pH on the 
mucus/polymer rheological synergism of polyacrylates has 
been examined using dynamic oscillatory rheology. It has 
been shown that an optimum mucus polymer interaction 
occurs not only at the pKa value but also at the pH regimes 
unique to each polymer type, being influenced by the 
hydrogen-bonded interactions. 
Measurement of The Residence Time / in-Vivo Techniques 
Measurements of the residence time of bioadhesives at the 
application site provide quantitative information on their 
bioadhesive properties. The GIT transit time of many 
bioadhesive preparations have been examined using 
radioisotopes and the fluorescent labeling techniques. 
GI Transit Using Radio-Opaque Microspheres16 
It is a simple procedure involving the use of radio-opaque 
markers, e.g. barium sulfate, encapsulated in bioadhesive 
microspheres to determine the effects of bioadhesive 
polymers on GIT transit time. Faeces collection (using an 
automated faeces collection machine) and X-ray inspection 
provide a non-invasive method of monitoring total GIT 
residence time without affecting normal GIT motility.  
Bioadhesive labeled with Cr-51, Tc-99m, In-113m, or I-
123 has been used to study the transit of the microspheres 
in the GIT. 
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Gamma Scintigraphy Technique17 
Distribution and retention time of the bioadhesive 
intravaginal microspheres can be studied using the gamma 
scintigraphy technique. A study has reported the intensity 
and distribution of radioactivity in the genital tract after 
administration of technetium labelled HYAFF 
microspheres. Dimensions of the vaginal cavity of the 
sheep can be outlined and imaged using labelled gellan 
gum and the data collected is subsequently used to 
compare the distribution of radiolabelled HYAFF 
formulations. The retention of bioadhesive-radiolabelled 
microspheres based on HYAFF polymer was found to be 
more for the dry powder formulation than for the pessary 
formulation after 12 h of administration to vaginal 
epithelium. The combination of sheep model and gamma 
scintigraphy method has been proved to be an extremely 
useful tool for evaluating the distribution, spreading and 
clearance of vaginally administered Bioadhesive Drug 
Delivery Systems. 
 
                                          Table 1: Application of Bioadhesive Microspheres 
Drug Route of 
administration 
Polymer(s) Use Comments 
Acyclovir Ocular CH- Slow released rate increased AUC 
Methyl 
Pednisolole 
Ocular Hyaluronic acid Slow released rate, sustained drug concentration in 
tear fluids. 
Gentamycin Nasal DSM + LPC Increased nasal absorption. 
Insulin Nasal DSM + LPC Efficient delivery of insulin in to systemic 
Circulation via nasal route. 
Humanm growth 
hormones 
Nasal DSM + LPC Rapid & increased absorption. 
Desmopressin Nasal Starch Addition of LPC causes five folds increase in Cmax 
and to folds increase in Bioavailability. 
Haemagglutinin 
(HA) 
Nasal HYAFF With mucosal joint: increased serum IgG antibody 
response as compare to intramuscular immunization. 
Furosemide GIT AD-MMS 
(PGEFs) 
Increased Bioavailability, Higher AUC effective 
absorption from the absorption window. 
Riboflavin GIT AD-MMS (PGEFs) Increased bioavailability, Higher AUC effective 
absorption from the absorption window. 
Amoxicillin GIT AD-MMS (PGEFs) Greater anti H. Pylori activity. 
Vancomycin Colonic PGEF coated with 
Eudragit S 100 
Well absorbed even without absorption enhancers. 
Insulin Colonic PGEF coated with 
Eudragit S 100 
Absorbed only in the presence of absorption 
Enhancers. E.g. EDTA Salt 
Nerve growth 
factor (NGF) 
Vaginal HYAFF Increased absorption from HYAFF microspheres 
Salmon Calcitonin Vaginal HYAFF Increased absorption from HYAFF microspheres 
Pipemidic acid Vesical CMC as muco-
polyssacaride + Edugragit 
RL as Matrix polymer. 
Enhanced absorption of pipemidic acid though 
bioadhesion. 
Indomethacin Oral Alginate + Sodium CMC/ 
MC/Carbopol/ HPMC 
Slow release rates 
Glipitizide Oral Alginate + sodium CMC/ 
MC/Carbopol /HPMC 
Slow release rates 
 
AD-MMS: adhesive micromatrix system; AUC: area 
under curve; CMC: carboxy methyl cellulose: DSM: 
degradable starch microspheres; EDTA: ethylene 
diaminetetraacetic acid; GIT ; gastrointestinal tract; 
HYAFF : hyaluronic acid esters ; IgG : immunoglobulin 
G;  IM. : intramuscular; LPC:lysophatidylcholine ; MRT 
: mean residence time; PGEFs : polyglycerol esters of 
fatty acids ; MC : methyl cellulose ; HPMC : 
hydroxypropyl methylcellulose. 
CONCLUSION 
Bioadhesive microspheres offer unique carrier system for 
many pharmaceuticals and can be tailored to adhere to any 
mucosal tissue, including those found in eyes, oral cavity 
and throughout the respiratory, urinary and gastrointestinal 
tract. The bioadhesive microspheres can be used not only 
for controlled release but also for targeted delivery of the 
drugs to specific sites in body. Polymeric science needs to 
be explored to find newer bioadhesive polymers with the 
added attributes of being biodegradable, biocompatible, 
bioadhesive for specific cells or mucosa and which could 
also function as enzyme inhibitors for the successful 
delivery of proteins and peptides. 
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